Sarah Solomon on Muck Rack

Sarah Solomon

  • Content Strategist, 360i
New York
As seen in: Medium, Wiley Online Library, Cosmopolitan, The New Yorker, The Street, Apartment Therapy, Town & Country, JD Supra, BroBible, JNeurosci and
author, illustrator, and rodent czar of lower manhattan
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sarah

Contact Sarah, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Goodwin Advises Ascidian Therapeutics on a Global Research Collaboration with Eli Lilly for Up To $1.9 Billion

|
By Sarah Solomon
| Goodwin
The Life Sciences team advised Ascidian Therapeutics (Ascidian) on entering into a global research collaboration and licensing agreement with Eli Lilly and Company (Lilly) to discover and develop therapies for undisclosed monogenic kidney diseases, with the option to expand to additional targets. Under the agreement, Lilly will receive exclusive, target-specific rights to Ascidian’s RNA exon editing technology for undisclosed kidney disease targets.
Open in Who Shared Issue with article?

Stress-Resistant Symbiodiniaceae and Diverse Bacterial Communities Promote Coral Persistence in Variable, Multi-Stressor Environments

|
By Maya Powell, Sarah Solomon, Verena Schoepf
| Wiley Online Library
1 Introduction Coral reefs are declining worldwide due to the combined effects of climate change and local anthropogenic stressors (IPCC 2023). Acute and chronic stressors at the climate, regional, and local level can result in degraded environmental and ecological conditions, leading to regime shifts towards non-coral dominated states and reduced ecosystem functioning (Bell et al. 2021; Haas et al. 2016; Harborne et al. 2017).
Open in Who Shared Issue with article?

Goodwin Represents Nimbus Therapeutics in Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment for Up to $1.3 Billion | News & Events | Goodwin

|
By Sarah Solomon
| Goodwin
The Life Sciences team advised Nimbus Therapeutics, LLC (“Nimbus Therapeutics” or “Nimbus”) on entering a multi-year research collaboration and exclusive, worldwide license agreement with Eli Lilly and Company (“Lilly”) to develop a novel oral treatment for obesity and other metabolic diseases.
Open in Who Shared Issue with article?
See all 231 licensed articles (232 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Sarah

Contact Sarah, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified